About Transcend Medical
Transcend Medical is a company based in Menlo Park (United States) founded in 2006 was acquired by Alcon in February 2016.. Transcend Medical has raised $122.27 million across 4 funding rounds from investors including Alcon, Canaan and Finistere Ventures. The company has 20 employees as of December 31, 2017. Transcend Medical operates in a competitive market with competitors including Glaukos, Myra Vision, Ivantis, Sensimed and Avisi Technologies, among others.
- Headquarter Menlo Park, United States
- Employees 20 as on 31 Dec, 2017
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Transcend Medical, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Transcend Medical
Transcend Medical has successfully raised a total of $122.27M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $29.27 million completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $29.3M
-
First Round
First Round
(10 Nov 2006)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2015 | Amount | Series C - Transcend Medical | Valuation |
investors |
|
| Jul, 2011 | Amount | Series B - Transcend Medical | Valuation | Finistere Ventures , Kaiser Permanente Ventures | |
| Jun, 2009 | Amount | Series B - Transcend Medical | Valuation | HLM Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Transcend Medical
Transcend Medical has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Alcon, Canaan and Finistere Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canaan is recognized as an early-stage venture capital firm.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
VC firm investing in expansion stage tech and life sciences companies in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Transcend Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Transcend Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Transcend Medical Comparisons
Competitors of Transcend Medical
Transcend Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Glaukos, Myra Vision, Ivantis, Sensimed and Avisi Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of implants to treat glaucoma
|
|
| domain | founded_year | HQ Location |
Nanotechnology-based devices for glaucoma treatment are developed.
|
|
| domain | founded_year | HQ Location |
Implantable device to relieve intraocular pressure in open angle glaucoma
|
|
| domain | founded_year | HQ Location |
A contact lens-based platform for glaucoma monitoring is offered.
|
|
| domain | founded_year | HQ Location |
Nano-materials for glaucoma treatment implants are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Transcend Medical
Frequently Asked Questions about Transcend Medical
When was Transcend Medical founded?
Transcend Medical was founded in 2006.
Where is Transcend Medical located?
Transcend Medical is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is Transcend Medical a funded company?
Transcend Medical is a funded company, having raised a total of $122.27M across 4 funding rounds to date. The company's 1st funding round was a Series B of $35M, raised on Nov 10, 2006.
How many employees does Transcend Medical have?
As of Dec 31, 2017, the latest employee count at Transcend Medical is 20.
What does Transcend Medical do?
Transcend Medical was founded in 2006 and is headquartered in Menlo Park, United States. Medical devices for minimally invasive glaucoma interventions are developed by the company within the ophthalmology sector. The CyPass Micro-Stent, implanted in the supraciliary space, is designed to reduce intraocular pressure by creating a micro-cyclodialysis that bypasses the ciliary body and targets the suprachoroidal outflow pathway, similar to prostaglandin analogues.
Who are the top competitors of Transcend Medical?
Transcend Medical's top competitors include Glaukos, Myra Vision and Avisi Technologies.
Who are Transcend Medical's investors?
Transcend Medical has 10 investors. Key investors include Alcon, Canaan, Finistere Ventures, HLM Venture Partners, and Kaiser Permanente Ventures.